Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma

Glucose consumption in many types of cancer cells, in particular hepatocellular carcinoma (HCC), was followed completely by over-expression of type II hexokinase (HKII). This evidence has been used in modern pharmacotherapy to discover therapeutic target against glycolysis in cancer cells. Bromopyru...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanafy, Nemany A., Dini, Luciana, Citti, Cinzia, Cannazza, Giuseppe, Leporatti, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791121/
https://www.ncbi.nlm.nih.gov/pubmed/29320411
http://dx.doi.org/10.3390/nano8010034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791121/
https://www.ncbi.nlm.nih.gov/pubmed/29320411
http://dx.doi.org/10.3390/nano8010034

Ejemplares similares